Filing Flows › Charles River Laboratories International (CRL) › RMS revenue
Charles River Laboratories International (CRL) RMS revenue by quarter
Charles River Laboratories International's RMS revenue was $208M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026. Over the last 7 quarters it ranged from $206M (Q4 2025) to $213M (Q3 2025).
| Quarter | RMS revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $208M | -0.9% | -3% |
| Q2 2026 | $209M | +0.5% | -2% |
| Q1 2026 | $208M | +1% | -2% |
| Q4 2025 | $206M | -3% | — |
| Q3 2025 | $213M | +0.1% | — |
| Q2 2025 | $213M | +0.1% | — |
| Q1 2025 | $213M | — | — |
Q3 2026 at a glance
Charles River Laboratories International, Q3 2026: revenue $983M (-2% year over year), operating margin 20.6%, net earnings $333M, operating cash flow $254M. The chart follows the revenue to costs, profit and cash.
Questions
What is Charles River Laboratories International's RMS revenue?
Charles River Laboratories International's RMS revenue was $208M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026.
How has Charles River Laboratories International's RMS revenue changed?
Over the last 7 quarters it ranged from $206M (Q4 2025) to $213M (Q3 2025).
Q3 2026 results → · How Charles River Laboratories International makes money →